Danimer Scientific, Inc. (DNMR)
NYSE: DNMR · IEX Real-Time Price · USD
0.775
-0.018 (-2.23%)
Apr 19, 2024, 4:00 PM EDT - Market closed

Company Description

Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally.

It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.

The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles.

It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry.

Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.

Danimer Scientific, Inc.
Danimer Scientific logo
Country United States
Founded 2004
Industry Specialty Chemicals
Sector Materials
Employees 257
CEO Stephen E. Croskrey

Contact Details

Address:
140 Industrial Boulevard
Bainbridge, Georgia 39817
United States
Phone 229-243-7075
Website danimerscientific.com

Stock Details

Ticker Symbol DNMR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001779020
CUSIP Number 236272100
ISIN Number US2362721001
Employer ID 84-1924518
SIC Code 2821

Key Executives

Name Position
Stephen E. Croskrey Chief Executive Officer and Chairman of the Board
Michael A. Hajost Chief Financial Officer
Scott C. Tuten Chief Marketing and Sustainability Officer
Michael Smith Chief Operating Officer
Russ Zukowski Vice President of Corporate Finance
Phillip D. Van Trump Chief Science and Technology Officer
James Palczynski Investor Relations Officer
Stephen Albert Martin Esq. Corporate Secretary and Chief Legal Officer
Anthony L. Austin Chief Human Resource Officer
John A. Dowdy III Senior Vice President of Financial Planning and Analysis

Latest SEC Filings

Date Type Title
Apr 1, 2024 424B3 Prospectus
Mar 29, 2024 10-K Annual Report
Mar 28, 2024 8-K Current Report
Mar 25, 2024 8-K Current Report
Mar 22, 2024 424B5 Filing
Mar 21, 2024 424B5 Filing
Mar 20, 2024 8-K Current Report
Jan 30, 2024 424B3 Prospectus
Jan 29, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 29, 2024 8-K Current Report